Thromboprophylaxis in acutely ill medical patients: results of a survey among Italian physicians

Thromb Res. 2014 Sep;134(3):572-7. doi: 10.1016/j.thromres.2014.06.013. Epub 2014 Jun 16.

Abstract

Aims: acutely ill medical patients are at increased risk of venous thromboembolism (VTE) and often require thromboprophylaxis, but patient selection and adequate therapeutic decisions may be difficult due to the heterogeneity and the complexity of this population. We conducted a survey among a large cohort of Italian physicians to assess their approach to some important "grey" areas of VTE prevention in this setting.

Methods: a questionnaire was distributed during the meeting of a national society of Internal Medicine (FADOI), held in May 2013. Four clinical scenarios describing areas of clinical uncertainty were administered to participants: the first on a patient with acute ischemic stroke; the second on a patient with severe renal insufficiency; the third on the duration of prophylaxis in the post-acute setting; and the last on a patient at high risk of VTE and at moderate risk of bleeding with preserved mobility.

Results: 453 questionnaires were returned (participants mean age 48.5 years). About 70% of participants systematically assess VTE and bleeding risk in their clinical practice, but a minority of them use risk assessment models. Prolonged prophylaxis in the post-acute setting was voted by more than eighty percent of participants; replies to the other three clinical scenarios were more heterogeneous with none of the options selected by more than 60% of participant.

Conclusion: physicians approach to "grey" areas of antithrombotic prophylaxis in the medical setting is quite heterogeneous and sometimes partially in contrast to recent guidelines, reinforcing the need for educational programs and high quality studies in this setting.

Keywords: RAMs; bleeding risk; thromboprophylaxis; venous thromboembolism.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Ischemia / complications
  • Brain Ischemia / diagnosis
  • Brain Ischemia / drug therapy*
  • Decision Support Techniques
  • Female
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Health Care Surveys
  • Hemorrhage / chemically induced
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Practice Patterns, Physicians'*
  • Predictive Value of Tests
  • Renal Insufficiency / complications
  • Renal Insufficiency / diagnosis
  • Renal Insufficiency / drug therapy*
  • Risk Assessment
  • Risk Factors
  • Stroke / complications
  • Stroke / diagnosis
  • Stroke / drug therapy*
  • Surveys and Questionnaires
  • Treatment Outcome
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*

Substances

  • Fibrinolytic Agents